ATF7
ATF7 (activating transcription factor 7, also known as ATFA) is a member of the bZIP family of transcription factors and belongs to the activating transcription factor 2 family. It binds DNA and regulates transcription by RNA polymerase II, acting as a repressor and, in some contexts, as an activator. Browse Assay Genie's current range of ATF7 research reagents below, or read on for the biology behind the target.
ATF7 is a transcription factor of the bZIP family. According to UniProt, it acts as a negative regulator, inhibiting both ATF2 and ATF7 transcriptional activities. This effect may arise through sequestration in the cytoplasm of the kinase that phosphorylates Thr-53, which would prevent activation. The NCBI Gene summary adds that the protein enables DNA-binding transcription repressor activity specific to RNA polymerase II, mitogen-activated protein kinase binding and transcription coactivator binding.
Functionally, ATF7 is involved in both negative and positive regulation of transcription by RNA polymerase II, so its output depends on context rather than being purely repressive. Its ability to bind mitogen-activated protein kinases places it in the group of transcription factors that can be controlled by kinase signalling. The protein is located mainly in the nucleus, and UniProt also records it in the nucleoplasm, at telomeres and in the cytoplasm. The cytoplasmic pool is relevant to the proposed kinase-sequestration mechanism.
The ATF7 gene encodes the protein UniProt names cyclic AMP-dependent transcription factor ATF-7. HGNC lists it with the C2H2-type zinc finger genes and in the activating transcription factor 2 family, alongside ATF2, and it is also known by the alias ATFA. A mouse ortholog, Atf7, is recorded. In disease research, the NCBI Gene summary describes ATF7 as a biomarker of colorectal cancer. Studies of ATF7 therefore connect basic transcriptional control with kinase signalling and cancer biology.
ATF7 has DNA-binding transcription repressor activity and takes part in both negative and positive regulation of RNA polymerase II transcription.
The protein binds mitogen-activated protein kinases, and may sequester the Thr-53 phosphorylating kinase in the cytoplasm to limit activation.
ATF7 inhibits the transcriptional activities of both ATF2 and ATF7, making it useful for studying how related bZIP factors are controlled.
ATF7 is described as a biomarker of colorectal cancer, supporting its study in tumour biology and transcriptional dysregulation.
ATF7 is a bZIP transcription factor that UniProt describes as a negative regulator, inhibiting the transcriptional activities of ATF2 and ATF7. It may do so by sequestering the Thr-53 phosphorylating kinase in the cytoplasm. NCBI Gene also links it to both negative and positive regulation of RNA polymerase II transcription.
The HGNC-approved name is activating transcription factor 7, and UniProt calls the protein cyclic AMP-dependent transcription factor ATF-7. The alias ATFA is also used. HGNC lists no previous names. Searching under several of these names helps when comparing literature and datasets.
A mouse ortholog, Atf7, is recorded, which allows the gene to be studied in mouse models. For disease, the NCBI Gene summary describes ATF7 as a biomarker of colorectal cancer. Check the datasheet of any product for its validated reactivity.
Other activating transcription factor family members and bZIP transcription regulators with products at Assay Genie.
Gene and protein annotations from HGNC, NCBI Gene and UniProt P17544; product specifications from Assay Genie datasheets.